Company Quick10K Filing
QNB
10-Q 2020-06-30 Filed 2020-08-07
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-03-13
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-14
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-03-15
10-Q 2016-09-30 Filed 2016-11-08
10-Q 2016-06-30 Filed 2016-08-08
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-03-14
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-13
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-29
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-29
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-30
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-01
8-K 2020-07-28 Earnings, Exhibits
8-K 2020-05-26
8-K 2020-05-06
8-K 2020-04-28
8-K 2020-01-30
8-K 2019-10-25
8-K 2019-07-23
8-K 2019-05-28
8-K 2019-04-23
8-K 2019-01-25
8-K 2018-10-23
8-K 2018-06-30
8-K 2018-05-22
8-K 2018-04-24
8-K 2018-02-20
8-K 2018-01-10
8-K 2018-01-03
8-K 2017-12-31

QNB Financials

QNBC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Invesco DB Gold Fund (DGL) 174 9.8 10% 174 4 0 0 18 18 174
Fulcrum Therapeutics (FULC) 173 -2.4 -26% 116 14 0 0 -30 -30 71
MariMed (MRMD) 172 39% 23.2 -2% 137 54 40 16 -2 9 212
Fortem Resources (FTMR) 191 -119.9 -1% 143 19 0 0 -2 -2 192
Cure Pharmaceutical (CURR) 171 94% -10.1 -60% 34 21 0 0 -20 -16 166
FC Global Realty (FCRE) 171 86% -62.4 -2% 134 53 0 0 -3 -3 171
Applied Therapeutics (APLT) 170 -5.6 -75% 37 7 0 0 -28 -28 157
SWK Holdings (SWKH) 167 0% 9.7 6% 248 20 21 0 15 17 163
DOCASA (DCSA) 167 24% -117.8 -8% 22 7 6 2 -2 -1 166
Jamba (JMBA) 165 0% 68.1 -4% 37 47 78 0 -2 2 156
QNB (QNBC) 162 5.6 1% 1,246 1,127 0 0 12 25 141
Diverse Development Group (DDG) 161 -3,433.4 -24,302% 0 0 0 0 -0 -0 161
Gold Reserve (GDRZF) 161 -8.9 -15% 78 104 0 0 -12 -12 103
Blackstar Enterprise Group (BEGI) 156 -313.5 -13,158% 0 0 0 0 -0 -0 156
Invesco CurrencyShares British Pound Sterling Trust (FXB) 156 0% -5.1 -0% 155 0 0 0 -0 -0 0
Northwest Indiana Bancorp (NWIN) 154 4.5 1% 1,330 1,197 0 0 10 18 82
Franklin Financial Services (FRAF) 152 0.1 1% 1,302 1,176 0 0 16 26 2
Pacific Green Technologies (PGTK) 152 39% -24.6 -8% 82 67 70 27 -7 -6 140
Datawatch (DWCH) 152 0% -21.0 -15% 62 35 42 0 -9 -7 146
Invesco CurrencyShares Swiss Franc Trust (FXF) 151 -11.9 -1% 144 0 0 0 -2 -1 7

Balance Sheet ($MM)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3211321215211620162220651845217017325869112115261630121413141421
Accounts Receivable
Inventory
PP&E78882310109251010102610992799927999279101030121215
Assets8758698839349209199119399339349169959779939551,0391,0211,0051,0301,0721,0631,0891,1211,1501,1521,1721,1731,1841,1751,2031,2121,246
Accounts Payable
Long-Term Debt2020205565555
Liabilities8067988108578428408378638578558339128919048679489309109339749709931,0221,0501,0541,0761,0751,0861,0711,0931,0961,127
Stockholders' Equity697173777878747676798383868989919095979894969910199979899104110116119
Income Statement ($MM)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A0000000000000000000000000000000
Tax1111110111111111111111213111-0111
Net Income22222222222222222222232303332333
Cash Flow ($MM)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating33-17244-2233134233135444335145
Cash Investing-166204-6-27281118-35-281315-36-4033-1-27-59-16-39-19-17-10-20-11-18-8-25
Cash Financing-912-16-6-126-7-3-2278-2313-4282-15-222337-3212927321-0817427